UK Market for IVDs shows an Increase of 50% in Two Years

No-one can be surprised that the COVID-19 pandemic has had a dramatic effect on IVD revenues in the UK as in the rest of the world. As the BIVDA Market Audit (MA) shows for the 12 months to June 2021, revenues have increased by over 50%, and, of course, most of that increase is due directly to testing for Coronavirus.

The lockdown caused a temporary near-suspension of routine diagnostic services, leading to drops in these testing figures. However, various other specific tests did show an increase, as the need arose for monitoring and diagnosing the complications of a COVID-19 infection, and to differentiate it from other respiratory infections.

The graph below shows the impact by testing area, although these numbers do not take into account glucose self-testing or the Government’s contracts for Lateral Flow Tests (LFTs) that were awarded to non-BIVDA member companies.

For the detail and analysis behind these, and for the only reliable source of UK market data for IVDs, ensure your company is a participant in the Market Audit. Not only BIVDA member companies can take part in the Market Audit. Any IVD company with sales in the United Kingdom can take part in it, for a fee. If in doubt, or for more information, contact the BIVDA team at enquiries@bivda.org.uk.